financetom
Business
financetom
/
Business
/
--PPL Keeps Quarterly Dividend at $0.2725 per Share; Payable July 1 to Holders of Record as of June 10
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--PPL Keeps Quarterly Dividend at $0.2725 per Share; Payable July 1 to Holders of Record as of June 10
May 26, 2025 9:45 AM

02:49 PM EDT, 05/16/2025 (MT Newswires) --

Price: 34.72, Change: +0.30, Percent Change: +0.86

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CME Group profit rises on trading strength
CME Group profit rises on trading strength
Oct 23, 2024
Oct 23 (Reuters) - CME Group ( CME ) reported a rise in third-quarter profit on Wednesday, as uncertainty around the U.S. monetary policy path led investors to rejig their portfolio, bolstering trading volumes for the derivatives exchange. Net income attributable to common shareholders of CME Group ( CME ) rose to $901.3 million, or $2.50 per share, in the...
Wabtec raises annual profit forecast on strong freight and transit demand
Wabtec raises annual profit forecast on strong freight and transit demand
Oct 23, 2024
Oct 23 (Reuters) - Heavy industrial parts maker Wabtec raised its full-year profit forecast on Wednesday, amid strong demand for its freight and transit products. The Pittsburgh, Pennsylvania-based company is a provider of equipment, systems and aftermarket services for freight and transit rail industries. Wabtec now expects full-year adjusted profit in the range of $7.45 per share to $7.65 per...
Beyond Fires Chief Product Officer as Layoffs Take Effect
Beyond Fires Chief Product Officer as Layoffs Take Effect
Oct 23, 2024
07:03 AM EDT, 10/23/2024 (MT Newswires) -- Beyond (BYON) said Tuesday it terminated former Chief Product Officer Carlisha Robinson without cause, effective immediately, as part of its broader staff cuts. Beyond said the staff reduction plan was approved over the weekend, affecting approximately 20% of its workforce. The layoffs are expected to be substantially implemented by Q4. The move is...
Johnson & Johnson's Janssen-Cilag Says EU Approves Indication Extension for Multiple Myeloma Treatment
Johnson & Johnson's Janssen-Cilag Says EU Approves Indication Extension for Multiple Myeloma Treatment
Oct 23, 2024
07:04 AM EDT, 10/23/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) company Janssen-Cilag International said Wednesday that the European Commission (EC) has approved an indication extension for its subcutaneous Darzalex formulation in combination with bortezomib, lenalidomide, and dexamethasone for patients with newly diagnosed multiple myeloma who are eligible for an autologous stem cell transplant. The drug, also known...
Copyright 2023-2025 - www.financetom.com All Rights Reserved